RT Journal Article
SR Electronic
T1 Low linoleic acid foods with added DHA given to Malawian children with severe acute malnutrition improves cognition: a randomized, triple blinded, controlled clinical trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.07.21263231
DO 10.1101/2021.09.07.21263231
A1 Stephenson, Kevin
A1 Callaghan-Gillespie, Meghan
A1 Maleta, Kenneth
A1 Nkhoma, Minyanga
A1 George, Matthews
A1 Park, Hui Gyu
A1 Lee, Reginald
A1 Humpheries-Cuff, Iona
A1 Lacombe, R J Scott
A1 Wegner, Donna R
A1 Canfield, Richard L
A1 Brenna, J Thomas
A1 Manary, Mark J
YR 2021
UL http://medrxiv.org/content/early/2021/09/12/2021.09.07.21263231.abstract
AB Background There is concern that the PUFA composition of ready-to-use therapeutic food (RUTF) for treatment of severe acute malnutrition (SAM) is suboptimal for neurocognitive recovery.Objective We tested the hypothesis that RUTF made with reduced amounts of linoleic acid, achieved using high oleic (HO) peanuts, with or without added DHA, improves cognition when compared to standard RUTF (S-RUTF).Methods A triple-blind, randomized, controlled clinical feeding trial was conducted among children with uncomplicated SAM in Malawi with 3 types of RUTF; DHA-HO-RUTF, HO-RUTF and S-RUTF. The primary outcomes, measured in a subset of subjects, were the Malawi Developmental Assessment Tool (MDAT) global and 4 domain (gross motor, fine motor, language and social) z-scores and a modified Willatts problem solving assessment (PSA) intention score for 3 standardized problems, measured 6 months and immediately after completing RUTF therapy, respectively. Plasma fatty acid content, anthropometry and eye tracking were secondary outcomes. Comparisons were made between the novel PUFA RUTFs and S-RUTF.Results Among the 2565 SAM children enrolled, global MDAT z-score was -0.69 ± 1.19 and - 0.88 ± 1.27 for children receiving DHA-HO-RUTF and S-RUTF, respectively (difference 0.19, 95% CI 0.01 to 0.38). The gross motor and social domains had higher z-scores among children receiving either DHA-HO-RUTF than S-RUTF. The PSA problem 3 scores did not differ by dietary group (Odds ratio 0.92, 95% CI 0.67 to 1.26 for DHA-HO-RUTF). After 4 weeks of treatment, plasma phospholipid EPA and α-linolenic acid were greater in children consuming DHA-HO-RUTF or HO-RUTF when compared to S-RUTF (for all 4 comparisons P values < 0.001), but only plasma DHA was greater in DHA-HO-RUTF than S-RUTF (P <0.001).Conclusions Treatment of uncomplicated SAM with DHA-HO-RUTF resulted in an improved MDAT score, conferring a cognitive benefit six months after completing diet therapy. This treatment should be explored in operational settings.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03094247Funding StatementFunding was generously provided by Unorthodox Philanthropy, Open Philanthropy and the Hickey Family Foundation. Wiley Companies supported the work with a donation of ingredients for one of the study foods.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial was approved by the Human Studies Committee of Washington University and the College of Medicine Research and Ethics Committee of the University of Malawi.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData described in the manuscript, code book, and analytic code will be made available upon request pending application to the corresponding author and approval.ALAα-linolenic acid;DHAdocosahexaenoic acid;DHA-HO-RUTFhigh oleic acid RUTF with added DHA;EPAeicosapentaenoic acid;HAZheight-for-age z-score;HO-RUTFhigh oleic acid RUTF;LAlinoleic acid;MDATMalawi Developmental Assessment Tool;MUACmid-upper arm circumference;PSAproblems solving assessment;PUFApolyunsaturated fatty acid;RUTFready-to-use therapeutic food;SAMsevere acute malnutrition;S-RUTFstandard RUTF;WHZweight-for-height z-score